These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 29669885

  • 1. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD, Wolf JJ, Liu D, Gres AT, Tang J, Boschert KN, Puray-Chavez MN, Pineda DL, Laughlin TG, Coonrod EM, Yang Q, Ji J, Kirby KA, Wang Z, Sarafianos SG.
    mSphere; 2018 Apr 25; 3(2):. PubMed ID: 29669885
    [Abstract] [Full Text] [Related]

  • 2. BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy.
    Rat V, Seigneuret F, Burlaud-Gaillard J, Lemoine R, Hourioux C, Zoulim F, Testoni B, Meunier JC, Tauber C, Roingeard P, de Rocquigny H.
    Antiviral Res; 2019 Sep 25; 169():104557. PubMed ID: 31302151
    [Abstract] [Full Text] [Related]

  • 3. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
    Ko C, Bester R, Zhou X, Xu Z, Blossey C, Sacherl J, Vondran FWR, Gao L, Protzer U.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31658963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly.
    Stray SJ, Zlotnick A.
    J Mol Recognit; 2006 Dec 20; 19(6):542-8. PubMed ID: 17006877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly.
    Stray SJ, Bourne CR, Punna S, Lewis WG, Finn MG, Zlotnick A.
    Proc Natl Acad Sci U S A; 2005 Jun 07; 102(23):8138-43. PubMed ID: 15928089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein.
    Wang J, Zhang H, Zhang Y, Jiang D, Li J, Goldmann S, Ren Q, Fei R, Wang X, Wei L.
    J Med Virol; 2017 Oct 07; 89(10):1804-1810. PubMed ID: 28401569
    [Abstract] [Full Text] [Related]

  • 12. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
    Hofmann S, Luther J, Plank V, Oswald A, Mai J, Simons I, Miller J, Falcone V, Hansen-Palmus L, Hengel H, Nassal M, Protzer U, Schreiner S.
    Microbiol Spectr; 2024 May 02; 12(5):e0378823. PubMed ID: 38567974
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors.
    Boucle S, Lu X, Bassit L, Ozturk T, Russell OO, Amblard F, Coats SJ, Schinazi RF.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):904-910. PubMed ID: 28094179
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM, Espiritu C, Vogel R, Ren S, Lau V, Kelly M, Kuduk SD, Hartman GD, Flores OA, Klumpp K.
    Antimicrob Agents Chemother; 2019 Jan 15; 63(1):. PubMed ID: 30373799
    [Abstract] [Full Text] [Related]

  • 18. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
    Berke JM, Dehertogh P, Vergauwen K, Mostmans W, Vandyck K, Raboisson P, Pauwels F.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32094138
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
    Viswanathan U, Mani N, Hu Z, Ban H, Du Y, Hu J, Chang J, Guo JT.
    Antiviral Res; 2020 Oct 21; 182():104917. PubMed ID: 32818519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.